These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7750726)

  • 1. [Treatment of chronic delta hepatitis with interferon alpha].
    Guyader D
    Gastroenterol Clin Biol; 1995 Feb; 19(2):236-8. PubMed ID: 7750726
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of IFN in the therapy of chronic delta hepatitis].
    Sagnelli E; Messina V
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):103-6. PubMed ID: 7619954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon alpha and chronic viral hepatitis].
    Ouzan D
    Rev Prat; 1994 Sep; 44(13):1714-8. PubMed ID: 7939251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of chronic delta hepatitis: overview.
    Hoofnagle JH; Di Bisceglie AM
    Prog Clin Biol Res; 1993; 382():337-43. PubMed ID: 8502700
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic type D (delta) hepatitis with alpha interferon.
    Rosina F; Rizzetto M
    Semin Liver Dis; 1989 Nov; 9(4):264-6. PubMed ID: 2690350
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B.
    Schalm SW
    Neth J Med; 1994 Mar; 44(3):103-9. PubMed ID: 8202205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data?].
    Gerken G
    Internist (Berl); 1993 Nov; 34(11):1062-5. PubMed ID: 8282492
    [No Abstract]   [Full Text] [Related]  

  • 11. Italian trials of interferon alpha in chronic delta hepatitis.
    Rosina F; Saracco G; Cozzolongo R; Costa C; Bonino F; Verme G; Rizzetto M
    Prog Clin Biol Res; 1993; 382():353-8. PubMed ID: 8502703
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic hepatitis: the etiological spectrum. The implications for treatment].
    Velosa J; Ramalho F; Serejo F; Marinho R; de Moura MC
    Acta Med Port; 1993 Jun; 6(6):233-8. PubMed ID: 8368089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of interferon-alpha treatment of hepatitis D virus infection.
    Malaguarnera M; Restuccia S; Pistone G; Ruello P; Giugno I; Trovato BA
    Pharmacotherapy; 1996; 16(4):609-14. PubMed ID: 8840366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term interferon treatment of chronic hepatitis D: a multicentre Italian study.
    Rosina F; Pintus C; Rizzetto M
    J Hepatol; 1990; 11 Suppl 1():S149-50. PubMed ID: 2079574
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined therapy with recombinant alfa-2 and gamma interferons in patients with chronic hepatitis delta virus infection].
    Fedorchenko SV
    Klin Med (Mosk); 1996; 74(2):35-7. PubMed ID: 8772100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment with alpha-interferon of HBV and HDV coinfection. Case report of a 4-year-old boy].
    Pawłowska J; Burczyńska B; Kluge P; Socha J
    Pediatr Pol; 1995 May; 70(5):427-30. PubMed ID: 8692597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].
    Yoo BC; Kim HJ; Do JH; Park SM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
    Knolle PA; Eckardt AJ; Protzer-Knolle U; Schirmacher P; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines.
    Yurdaydın C; Tabak F; Kaymakoğlu S; Akarsu M; Akıncı EG; Akkız H; Alkım C; Çekin AH; Çuvalcı NÖ; Demir K; Değertekin B; Dökmetaş İ; Ersöz G; Hizel K; Kandemir FÖ; Önlen Y; Sonsuz A; Şenateş E; Tosun S; Tözün N; Idilman R; Guidelines Study Group VH
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):84-89. PubMed ID: 29303104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.